1. Home
  2. FUBO vs TYRA Comparison

FUBO vs TYRA Comparison

Compare FUBO & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo fuboTV Inc.

FUBO

fuboTV Inc.

HOLD

Current Price

$2.71

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$25.41

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUBO
TYRA
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
FUBO
TYRA
Price
$2.71
$25.41
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$5.35
$32.17
AVG Volume (30 Days)
10.3M
603.8K
Earning Date
11-03-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$1,616,726,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.99
N/A
P/E Ratio
$7.99
N/A
Revenue Growth
1.70
N/A
52 Week Low
$1.21
$6.42
52 Week High
$6.45
$25.88

Technical Indicators

Market Signals
Indicator
FUBO
TYRA
Relative Strength Index (RSI) 35.57 75.08
Support Level $2.55 $22.43
Resistance Level $2.76 $23.74
Average True Range (ATR) 0.11 1.39
MACD 0.01 -0.00
Stochastic Oscillator 37.80 91.90

Price Performance

Historical Comparison
FUBO
TYRA

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: